| Attribute Group | attlist.DescriptorRecord |
<xs:attribute name="DescriptorClass" default="1"> <xs:simpleType> <xs:restriction base="xs:token"> <xs:enumeration value="1"/> <xs:enumeration value="2"/> <xs:enumeration value="3"/> <xs:enumeration value="4"/> </xs:restriction> </xs:simpleType> </xs:attribute> |
|
D000001 |
|
Calcimycin |
|
1974 |
|
11 |
|
19 |
|
2016 |
|
05 |
|
27 |
|
1984 |
|
01 |
|
01 |
|
Q000031 |
|
analogs & derivatives |
|
AA |
|
Q000276 |
|
immunology |
|
IM |
|
Q000493 |
|
pharmacokinetics |
|
PK |
|
Q000096 |
|
biosynthesis |
|
BI |
|
Q000627 |
|
therapeutic use |
|
TU |
|
Q000633 |
|
toxicity |
|
TO |
|
Q000506 |
|
poisoning |
|
PO |
|
Q000008 |
|
administration & dosage |
|
AD |
|
Q000009 |
|
adverse effects |
|
AE |
|
Q000819 |
|
agonists |
|
AG |
|
Q000097 |
|
blood |
|
BL |
|
Q000134 |
|
cerebrospinal fluid |
|
CF |
|
Q000138 |
|
chemical synthesis |
|
CS |
|
Q000744 |
|
contraindications |
|
CT |
|
Q000737 |
|
chemistry |
|
CH |
|
Q000652 |
|
urine |
|
UR |
|
Q000528 |
|
radiation effects |
|
RE |
|
Q000266 |
|
history |
|
HI |
|
Q000032 |
|
analysis |
|
AN |
|
Q000037 |
|
antagonists & inhibitors |
|
AI |
|
Q000145 |
|
classification |
|
CL |
|
Q000191 |
|
economics |
|
EC |
|
Q000302 |
|
isolation & purification |
|
IP |
|
Q000378 |
|
metabolism |
|
ME |
|
Q000494 |
|
pharmacology |
|
PD |
|
Q000592 |
|
standards |
|
ST |
|
Q000600 |
|
supply & distribution |
|
SD |
|
91(75); was A 23187 1975-90 (see under ANTIBIOTICS 1975-83) |
|
use CALCIMYCIN to search A 23187 1975-90 |
|
91; was A 23187 1975-90 (see under ANTIBIOTICS 1975-83) |
|
Antibiotics (1973-1974) |
|
Carboxylic Acids (1973-1974) |
|
D000900 |
|
Anti-Bacterial Agents |
|
D061207 |
|
Calcium Ionophores |
|
D03.633.100.221.173 |
|
M0000001 |
|
Calcimycin |
|
4-Benzoxazolecarboxylic acid, 5-(methylamino)-2-((3,9,11-trimethyl-8-(1-methyl-2-oxo-2-(1H-pyrrol-2-yl)ethyl)-1,7-dioxaspiro(5.5)undec-2-yl)methyl)-, (6S-(6alpha(2S*,3S*),8beta(R*),9beta,11alpha))- |
|
37H9VM9WZL |
|
An ionophorous, polyether antibiotic from Streptomyces chartreusensis. It binds and transports CALCIUM and other divalent cations across membranes and uncouples oxidative phosphorylation while inhibiting ATPase of rat liver mitochondria. The substance is used mostly as a biochemical tool to study the role of divalent cations in various biological systems. |
|
52665-69-7 (Calcimycin) |
|
M0000001 |
|
M0353609 |
|
T000002 |
|
Calcimycin |
|
1999 |
|
01 |
|
01 |
|
FDA SRS (2014) |
|
NLM (1975) |
|
M0353609 |
|
A-23187 |
|
0 |
|
M0000001 |
|
M0353609 |
|
T000001 |
|
A-23187 |
|
1990 |
|
03 |
|
08 |
|
NLM (1991) |
|
T000001 |
|
A 23187 |
|
T000004 |
|
A23187 |
|
1974 |
|
11 |
|
11 |
|
UNK (19XX) |
|
T000003 |
|
Antibiotic A23187 |
|
1990 |
|
03 |
|
08 |
|
NLM (1991) |
|
T000003 |
|
A23187, Antibiotic |
|
D000002 |
|
Temefos |
|
1999 |
|
01 |
|
01 |
|
2013 |
|
07 |
|
08 |
|
1991 |
|
01 |
|
01 |
|
Q000031 |
|
analogs & derivatives |
|
AA |
|
Q000276 |
|
immunology |
|
IM |
|
Q000493 |
|
pharmacokinetics |
|
PK |
|
Q000627 |
|
therapeutic use |
|
TU |
|
Q000633 |
|
toxicity |
|
TO |
|
Q000008 |
|
administration & dosage |
|
AD |
|
Q000009 |
|
adverse effects |
|
AE |
|
Q000819 |
|
agonists |
|
AG |
|
Q000097 |
|
blood |
|
BL |
|
Q000134 |
|
cerebrospinal fluid |
|
CF |
|
Q000138 |
|
chemical synthesis |
|
CS |
|
Q000744 |
|
contraindications |
|
CT |
|
Q000737 |
|
chemistry |
|
CH |
|
Q000652 |
|
urine |
|
UR |
|
Q000528 |
|
radiation effects |
|
RE |
|
Q000266 |
|
history |
|
HI |
|
Q000032 |
|
analysis |
|
AN |
|
Q000037 |
|
antagonists & inhibitors |
|
AI |
|
Q000145 |
|
classification |
|
CL |
|
Q000191 |
|
economics |
|
EC |
|
Q000302 |
|
isolation & purification |
|
IP |
|
Q000378 |
|
metabolism |
|
ME |
|
Q000494 |
|
pharmacology |
|
PD |
|
Q000592 |
|
standards |
|
ST |
|
Q000600 |
|
supply & distribution |
|
SD |
|
for use to kill or control insects, use no qualifiers on the insecticide or the insect; appropriate qualifiers may be used when other aspects of the insecticide are discussed such as the effect on a physiologic process or behavioral aspect of the insect; for poisoning, coordinate with ORGANOPHOSPHATE POISONING |
|
96; was ABATE 1972-95 (see under INSECTICIDES, ORGANOTHIOPHOSPHATE 1972-90) |
|
96; was ABATE 1972-95 (see under INSECTICIDES, ORGANOTHIOPHOSPHATE 1972-90) |
|
Insecticides (1966-1971) |
|
D007306 |
|
Insecticides |
|
D02.705.400.625.800 |
|
D02.705.539.345.800 |
|
D02.886.300.692.800 |
|
M0000002 |
|
Temefos |
|
Phosphorothioic acid, O,O'-(thiodi-4,1-phenylene) O,O,O',O'-tetramethyl ester |
|
ONP3ME32DL |
|
An organothiophosphate insecticide. |
|
3383-96-8 (Temefos) |
|
M0000002 |
|
M0352201 |
|
M0000002 |
|
M0352200 |
|
T000008 |
|
Temefos |
|
1999 |
|
01 |
|
01 |
|
FDA SRS (2014) |
|
INN (19XX) |
|
USAN (1974) |
|
T000007 |
|
Temephos |
|
1994 |
|
12 |
|
01 |
|
NLM (1996) |
|
M0352201 |
|
Abate |
|
0 |
|
M0000002 |
|
M0352201 |
|
T000005 |
|
Abate |
|
1994 |
|
11 |
|
14 |
|
NLM (1996) |
|
M0352200 |
|
Difos |
|
0 |
|
M0000002 |
|
M0352200 |
|
T000006 |
|
Difos |
|
1986 |
|
10 |
|
07 |
|
UNK (19XX) |
|
D000003 |
|
Abattoirs |
|
1999 |
|
01 |
|
01 |
|
2016 |
|
06 |
|
08 |
|
1966 |
|
01 |
|
01 |
|
Q000145 |
|
classification |
|
CL |
|
Q000191 |
|
economics |
|
EC |
|
Q000266 |
|
history |
|
HI |
|
Q000331 |
|
legislation & jurisprudence |
|
LJ |
|
Q000364 |
|
manpower |
|
MA |
|
Q000458 |
|
organization & administration |
|
OG |
|
Q000592 |
|
standards |
|
ST |
|
Q000600 |
|
supply & distribution |
|
SD |
|
Q000639 |
|
trends |
|
TD |
|
Q000656 |
|
utilization |
|
UT |
|
Q000706 |
|
statistics & numerical data |
|
SN |
|
Q000941 |
|
ethics |
|
ES |
|
WA 707 |
|
J01.576.423.200.700.100 |
|
J03.540.020 |
|
M0000003 |
|
Abattoirs |
|
Places where animals are slaughtered and dressed for market. |
|
T000009 |
|
Abattoirs |
|
1999 |
|
01 |
|
01 |
|
NLM (1966) |
|
T000009 |
|
Abattoir |
|
T000901742 |
|
Slaughter Houses |
|
2016 |
|
05 |
|
25 |
|
NLM (2017) |
|
T000901742 |
|
House, Slaughter |
|
T000901742 |
|
Houses, Slaughter |
|
T000901743 |
|
Slaughter House |
|
2016 |
|
05 |
|
25 |
|
NLM (2017) |
|
T000010 |
|
Slaughterhouses |
|
1974 |
|
03 |
|
29 |
|
UNK (19XX) |
|
T000010 |
|
Slaughterhouse |
|
D000004 |
|
Abbreviations as Topic |
|
1999 |
|
01 |
|
01 |
|
2007 |
|
07 |
|
09 |
|
1960 |
|
01 |
|
01 |
|
includes acronyms; do not confuse with Publication Type ABBREVIATIONS |
|
2008(1963) |
|
2008; see ABBREVIATIONS 1963-2007 |
|
L01.143.506.598.400.556.131 |
|
M0000004 |
|
Abbreviations as Topic |
|
Shortened forms of written words or phrases used for brevity. |
|
M0000004 |
|
M0511063 |
|
T698652 |
|
Abbreviations as Topic |
|
2007 |
|
05 |
|
31 |
|
NLM (2008) |
|
M0511063 |
|
Acronyms as Topic |
|
M0000004 |
|
M0511063 |
|
T701041 |
|
Acronyms as Topic |
|
2007 |
|
06 |
|
29 |
|
NLM (2008) |
|
D000005 |
|
Abdomen |
|
1999 |
|
01 |
|
01 |
|
2016 |
|
08 |
|
09 |
|
1966 |
|
01 |
|
01 |
|
Q000000981 |
|
diagnostic imaging |
|
DG |
|
Q000002 |
|
abnormalities |
|
AB |
|
Q000033 |
|
anatomy & histology |
|
AH |
|
Q000098 |
|
blood supply |
|
BS |
|
Q000196 |
|
embryology |
|
EM |
|
Q000254 |
|
growth & development |
|
GD |
|
Q000294 |
|
innervation |
|
IR |
|
Q000382 |
|
microbiology |
|
MI |
|
Q000469 |
|
parasitology |
|
PS |
|
Q000473 |
|
pathology |
|
PA |
|
Q000502 |
|
physiology |
|
PH |
|
Q000503 |
|
physiopathology |
|
PP |
|
Q000528 |
|
radiation effects |
|
RE |
|
Q000601 |
|
surgery |
|
SU |
|
Q000821 |
|
virology |
|
VI |
|
GEN: prefer specifics; abdom muscles = ABDOMINAL MUSCLES but RECTUS ABDOMINIS is available; abdominal pain = ABDOMINAL PAIN; abrupt dis requiring emerg surg = ABDOMEN, ACUTE |
|
D000005 |
|
Abdomen |
|
Q000293 |
|
injuries |
|
D000007 |
|
Abdominal Injuries |
|
A01.923.047 |
|
M0000005 |
|
Abdomen |
|
That portion of the body that lies between the THORAX and the PELVIS. |
|
T000012 |
|
Abdomen |
|
1999 |
|
01 |
|
01 |
|
NLM (1966) |
|
T000012 |
|
Abdomens |
|
D000006 |
|
Abdomen, Acute |
|
1999 |
|
01 |
|
01 |
|
2015 |
|
07 |
|
08 |
|
1966 |
|
01 |
|
01 |
|
Q000469 |
|
parasitology |
|
PS |
|
Q000276 |
|
immunology |
|
IM |
|
Q000382 |
|
microbiology |
|
MI |
|
Q000175 |
|
diagnosis |
|
DI |
|
Q000000981 |
|
diagnostic imaging |
|
DG |
|
Q000503 |
|
physiopathology |
|
PP |
|
Q000534 |
|
rehabilitation |
|
RH |
|
Q000201 |
|
enzymology |
|
EN |
|
Q000209 |
|
etiology |
|
ET |
|
Q000401 |
|
mortality |
|
MO |
|
Q000453 |
|
epidemiology |
|
EP |
|
Q000517 |
|
prevention & control |
|
PC |
|
Q000097 |
|
blood |
|
BL |
|
Q000134 |
|
cerebrospinal fluid |
|
CF |
|
Q000139 |
|
chemically induced |
|
CI |
|
Q000151 |
|
congenital |
|
CN |
|
Q000178 |
|
diet therapy |
|
DH |
|
Q000188 |
|
drug therapy |
|
DT |
|
Q000628 |
|
therapy |
|
TH |
|
Q000523 |
|
psychology |
|
PX |
|
Q000652 |
|
urine |
|
UR |
|
Q000821 |
|
virology |
|
VI |
|
Q000662 |
|
veterinary |
|
VE |
|
Q000266 |
|
history |
|
HI |
|
Q000145 |
|
classification |
|
CL |
|
Q000150 |
|
complications |
|
CO |
|
Q000191 |
|
economics |
|
EC |
|
Q000196 |
|
embryology |
|
EM |
|
Q000235 |
|
genetics |
|
GE |
|
Q000378 |
|
metabolism |
|
ME |
|
Q000451 |
|
nursing |
|
NU |
|
Q000532 |
|
radiotherapy |
|
RT |
|
Q000601 |
|
surgery |
|
SU |
|
Q000208 |
|
ethnology |
|
EH |
|
Q000473 |
|
pathology |
|
PA |
|
WI 900 |
|
C10.597.617.044.200 |
|
C23.888.592.612.054.200 |
|
C23.888.821.030.249 |
|
M0000006 |
|
Abdomen, Acute |
|
A clinical syndrome with acute abdominal pain that is severe, localized, and rapid in onset. Acute abdomen may be caused by a variety of disorders, injuries, or diseases. |
|
T000013 |
|
Abdomen, Acute |
|
1999 |
|
01 |
|
01 |
|
NLM (1966) |
|
T000013 |
|
Abdomens, Acute |
|
T000013 |
|
Acute Abdomen |
|
T000013 |
|
Acute Abdomens |
|
D000007 |
|
Abdominal Injuries |
|
1999 |
|
01 |
|
01 |
|
2010 |
|
06 |
|
25 |
|
1966 |
|
01 |
|
01 |
|
Q000469 |
|
parasitology |
|
PS |
|
Q000276 |
|
immunology |
|
IM |
|
Q000382 |
|
microbiology |
|
MI |
|
Q000175 |
|
diagnosis |
|
DI |
|
Q000000981 |
|
diagnostic imaging |
|
DG |
|
Q000503 |
|
physiopathology |
|
PP |
|
Q000534 |
|
rehabilitation |
|
RH |
|
Q000201 |
|
enzymology |
|
EN |
|
Q000209 |
|
etiology |
|
ET |
|
Q000401 |
|
mortality |
|
MO |
|
Q000453 |
|
epidemiology |
|
EP |
|
Q000517 |
|
prevention & control |
|
PC |
|
Q000097 |
|
blood |
|
BL |
|
Q000134 |
|
cerebrospinal fluid |
|
CF |
|
Q000139 |
|
chemically induced |
|
CI |
|
Q000151 |
|
congenital |
|
CN |
|
Q000178 |
|
diet therapy |
|
DH |
|
Q000188 |
|
drug therapy |
|
DT |
|
Q000628 |
|
therapy |
|
TH |
|
Q000523 |
|
psychology |
|
PX |
|
Q000652 |
|
urine |
|
UR |
|
Q000821 |
|
virology |
|
VI |
|
Q000662 |
|
veterinary |
|
VE |
|
Q000266 |
|
history |
|
HI |
|
Q000145 |
|
classification |
|
CL |
|
Q000150 |
|
complications |
|
CO |
|
Q000191 |
|
economics |
|
EC |
|
Q000196 |
|
embryology |
|
EM |
|
Q000235 |
|
genetics |
|
GE |
|
Q000378 |
|
metabolism |
|
ME |
|
Q000451 |
|
nursing |
|
NU |
|
Q000532 |
|
radiotherapy |
|
RT |
|
Q000601 |
|
surgery |
|
SU |
|
Q000208 |
|
ethnology |
|
EH |
|
Q000473 |
|
pathology |
|
PA |
|
general term for inj of organs in the abdom cavity; prefer specific organs /inj |
|
WI 900 |
|
C26.017 |
|
M0000007 |
|
Abdominal Injuries |
|
General or unspecified injuries involving organs in the abdominal cavity. |
|
T000015 |
|
Abdominal Injuries |
|
1999 |
|
01 |
|
01 |
|
ABDOMINAL INJ |
|
NLM (1966) |
|
T000014 |
|
Injuries, Abdominal |
|
1986 |
|
01 |
|
01 |
|
INJ ABDOMINAL |
|
UNK (19XX) |
|
T000014 |
|
Abdominal Injury |
|
T000014 |
|
Injury, Abdominal |
|
D000008 |
|
Abdominal Neoplasms |
|
1999 |
|
01 |
|
01 |
|
2015 |
|
11 |
|
24 |
|
1966 |
|
01 |
|
01 |
|
Q000469 |
|
parasitology |
|
PS |
|
Q000276 |
|
immunology |
|
IM |
|
Q000382 |
|
microbiology |
|
MI |
|
Q000175 |
|
diagnosis |
|
DI |
|
Q000000981 |
|
diagnostic imaging |
|
DG |
|
Q000503 |
|
physiopathology |
|
PP |
|
Q000534 |
|
rehabilitation |
|
RH |
|
Q000556 |
|
secondary |
|
SC |
|
Q000557 |
|
secretion |
|
SE |
|
Q000201 |
|
enzymology |
|
EN |
|
Q000209 |
|
etiology |
|
ET |
|
Q000401 |
|
mortality |
|
MO |
|
Q000453 |
|
epidemiology |
|
EP |
|
Q000517 |
|
prevention & control |
|
PC |
|
Q000097 |
|
blood |
|
BL |
|
Q000134 |
|
cerebrospinal fluid |
|
CF |
|
Q000139 |
|
chemically induced |
|
CI |
|
Q000151 |
|
congenital |
|
CN |
|
Q000178 |
|
diet therapy |
|
DH |
|
Q000188 |
|
drug therapy |
|
DT |
|
Q000628 |
|
therapy |
|
TH |
|
Q000737 |
|
chemistry |
|
CH |
|
Q000523 |
|
psychology |
|
PX |
|
Q000652 |
|
urine |
|
UR |
|
Q000821 |
|
virology |
|
VI |
|
Q000662 |
|
veterinary |
|
VE |
|
Q000266 |
|
history |
|
HI |
|
Q000098 |
|
blood supply |
|
BS |
|
Q000145 |
|
classification |
|
CL |
|
Q000150 |
|
complications |
|
CO |
|
Q000191 |
|
economics |
|
EC |
|
Q000196 |
|
embryology |
|
EM |
|
Q000235 |
|
genetics |
|
GE |
|
Q000378 |
|
metabolism |
|
ME |
|
Q000451 |
|
nursing |
|
NU |
|
Q000532 |
|
radiotherapy |
|
RT |
|
Q000601 |
|
surgery |
|
SU |
|
Q000208 |
|
ethnology |
|
EH |
|
Q000473 |
|
pathology |
|
PA |
|
Q000648 |
|
ultrastructure |
|
UL |
|
general term for neoplasms of organs in the abdominal cavity; prefer specific organ/neoplasm terms; coordinate IM with histological type of neoplasm if given (IM) |
|
C04.588.033 |
|
M0000008 |
|
Abdominal Neoplasms |
|
New abnormal growth of tissue in the ABDOMEN. |
|
T000016 |
|
Abdominal Neoplasms |
|
1999 |
|
01 |
|
01 |
|
ABDOMINAL NEOPL |
|
NLM (1966) |
|
T000016 |
|
Abdominal Neoplasm |
|
T000016 |
|
Neoplasm, Abdominal |
|
T000016 |
|
Neoplasms, Abdominal |
|
D000009 |
|
Abdominal Muscles |
|
1999 |
|
01 |
|
01 |
|
2016 |
|
05 |
|
31 |
|
1993 |
|
01 |
|
01 |
|
Q000469 |
|
parasitology |
|
PS |
|
Q000002 |
|
abnormalities |
|
AB |
|
Q000276 |
|
immunology |
|
IM |
|
Q000382 |
|
microbiology |
|
MI |
|
Q000000981 |
|
diagnostic imaging |
|
DG |
|
Q000502 |
|
physiology |
|
PH |
|
Q000503 |
|
physiopathology |
|
PP |
|
Q000557 |
|
secretion |
|
SE |
|
Q000201 |
|
enzymology |
|
EN |
|
Q000294 |
|
innervation |
|
IR |
|
Q000166 |
|
cytology |
|
CY |
|
Q000737 |
|
chemistry |
|
CH |
|
Q000187 |
|
drug effects |
|
DE |
|
Q000637 |
|
transplantation |
|
TR |
|
Q000821 |
|
virology |
|
VI |
|
Q000528 |
|
radiation effects |
|
RE |
|
Q000033 |
|
anatomy & histology |
|
AH |
|
Q000098 |
|
blood supply |
|
BS |
|
Q000196 |
|
embryology |
|
EM |
|
Q000254 |
|
growth & development |
|
GD |
|
Q000293 |
|
injuries |
|
IN |
|
Q000378 |
|
metabolism |
|
ME |
|
Q000601 |
|
surgery |
|
SU |
|
Q000473 |
|
pathology |
|
PA |
|
Q000648 |
|
ultrastructure |
|
UL |
|
/growth: coordinate with MUSCLE DEVELOPMENT; /embryol: coordinate with MUSCLE DEVELOPMENT if pertinent |
|
93; was ABDOMINAL WALL 1966-92 |
|
WI 900 |
|
use ABDOMINAL MUSCLES to search ABDOMINAL WALL 1966-92 |
|
93; was ABDOMINAL WALL 1963-92 |
|
D034861 |
|
Abdominal Wall |
|
A02.633.567.050 |
|
M0000009 |
|
Abdominal Muscles |
|
Muscles forming the ABDOMINAL WALL including RECTUS ABDOMINIS; ABDOMINAL OBLIQUE MUSCLES, transversus abdominis, pyramidalis muscles and quadratus abdominis. |
|
M0000009 |
|
M000615276 |
|
M0000009 |
|
M000615216 |
|
M0000009 |
|
M000616776 |
|
M0000009 |
|
M000615203 |
|
T000018 |
|
Abdominal Muscles |
|
1999 |
|
01 |
|
01 |
|
NLM (1966) |
|
T000018 |
|
Abdominal Muscle |
|
T000018 |
|
Muscle, Abdominal |
|
T000018 |
|
Muscles, Abdominal |
|
M000615276 |
|
Cremaster Muscle |
|
M0000009 |
|
M000615276 |
|
T000896272 |
|
Cremaster Muscle |
|
2016 |
|
03 |
|
02 |
|
NLM (2017) |
|
T000896272 |
|
Cremaster Muscles |
|
T000896272 |
|
Muscle, Cremaster |
|
T000896272 |
|
Muscles, Cremaster |
|
M000615216 |
|
Pyramidalis Muscle |
|
M0000009 |
|
M000615216 |
|
T000896111 |
|
Pyramidalis Muscle |
|
2016 |
|
02 |
|
29 |
|
NLM (2017) |
|
T000896111 |
|
Muscle, Pyramidalis |
|
T000896111 |
|
Muscles, Pyramidalis |
|
T000896111 |
|
Pyramidalis Muscles |
|
M000616776 |
|
Quadratus Abdominis |
|
M0000009 |
|
M000616776 |
|
T000898967 |
|
Quadratus Abdominis |
|
2016 |
|
04 |
|
15 |
|
NLM (2017) |
|
T000898967 |
|
Abdomini, Quadratus |
|
T000898967 |
|
Abdominis, Quadratus |
|
T000898967 |
|
Quadratus Abdomini |
|
M000615203 |
|
Transversus Abdominis |
|
M0000009 |
|
M000615203 |
|
T000896092 |
|
Transversus Abdominis |
|
2016 |
|
02 |
|
29 |
|
NLM (2017) |
|
T000896094 |
|
Transverse Abdominal |
|
2016 |
|
02 |
|
29 |
|
NLM (2017) |
|
T000896094 |
|
Abdominal, Transverse |
|
T000896094 |
|
Abdominals, Transverse |
|
T000896094 |
|
Transverse Abdominals |
|
D000010 |
|
Abducens Nerve |
|
1999 |
|
01 |
|
01 |
|
2014 |
|
06 |
|
20 |
|
1966 |
|
01 |
|
01 |
|
Q000469 |
|
parasitology |
|
PS |
|
Q000002 |
|
abnormalities |
|
AB |
|
Q000276 |
|
immunology |
|
IM |
|
Q000382 |
|
microbiology |
|
MI |
|
Q000000981 |
|
diagnostic imaging |
|
DG |
|
Q000502 |
|
physiology |
|
PH |
|
Q000503 |
|
physiopathology |
|
PP |
|
Q000557 |
|
secretion |
|
SE |
|
Q000201 |
|
enzymology |
|
EN |
|
Q000166 |
|
cytology |
|
CY |
|
Q000737 |
|
chemistry |
|
CH |
|
Q000187 |
|
drug effects |
|
DE |
|
Q000637 |
|
transplantation |
|
TR |
|
Q000821 |
|
virology |
|
VI |
|
Q000528 |
|
radiation effects |
|
RE |
|
Q000033 |
|
anatomy & histology |
|
AH |
|
Q000098 |
|
blood supply |
|
BS |
|
Q000196 |
|
embryology |
|
EM |
|
Q000254 |
|
growth & development |
|
GD |
|
Q000378 |
|
metabolism |
|
ME |
|
Q000601 |
|
surgery |
|
SU |
|
Q000473 |
|
pathology |
|
PA |
|
Q000648 |
|
ultrastructure |
|
UL |
|
neoplasms = ABDUCENS NERVE DISEASES (IM) + CRANIAL NERVE NEOPLASMS (IM) + histological type of neoplasm (IM) |
|
77; was ABDUCENT NERVE 1963-76 |
|
WL 330 |
|
use ABDUCENS NERVE to search ABDUCENT NERVE 1966-76 |
|
77; was ABDUCENT NERVE 1963-76 |
|
D000010 |
|
Abducens Nerve |
|
Q000293 |
|
injuries |
|
D020222 |
|
Abducens Nerve Injury |
|
D065827 |
|
Abducens Nucleus |
|
A08.800.800.120.030 |
|
M0000010 |
|
Abducens Nerve |
|
The 6th cranial nerve which originates in the ABDUCENS NUCLEUS of the PONS and sends motor fibers to the lateral rectus muscles of the EYE. Damage to the nerve or its nucleus disrupts horizontal eye movement control. |
|
T000019 |
|
Abducens Nerve |
|
1999 |
|
01 |
|
01 |
|
NLM (1966) |
|
T000019 |
|
Nerve, Abducens |
|
T000020 |
|
Sixth Cranial Nerve |
|
1996 |
|
07 |
|
31 |
|
NLM (1998) |
|
T000020 |
|
Cranial Nerve, Sixth |
|
T000020 |
|
Nerve, Sixth Cranial |
|
T000020 |
|
Nerves, Sixth Cranial |
|
T000020 |
|
Sixth Cranial Nerves |
|
T856510 |
|
Nerve VI |
|
2014 |
|
03 |
|
14 |
|
NLM (2015) |
|
T856510 |
|
Nerve VIs |
|
T856511 |
|
Nervus Abducens |
|
2014 |
|
03 |
|
14 |
|
NLM (2015) |
|
T856511 |
|
Abducen, Nervus |
|
T856511 |
|
Abducens, Nervus |
|
T856511 |
|
Nervus Abducen |
|
T000021 |
|
Abducent Nerve |
|
1976 |
|
05 |
|
26 |
|
UNK (19XX) |
|
T000021 |
|
Abducent Nerves |
|
T000021 |
|
Nerve, Abducent |
|
T000022 |
|
Cranial Nerve VI |
|
1996 |
|
07 |
|
31 |
|
NLM (1998) |
|
T000022 |
|
Cranial Nerve VIs |
|
T000022 |
|
Nerve VI, Cranial |
|
T000022 |
|
Nerve VIs, Cranial |
|
D000011 |
|
Abelson murine leukemia virus |
|
1979 |
|
04 |
|
16 |
|
2015 |
|
06 |
|
22 |
|
1991 |
|
01 |
|
01 |
|
Q000145 |
|
classification |
|
CL |
|
Q000187 |
|
drug effects |
|
DE |
|
Q000201 |
|
enzymology |
|
EN |
|
Q000235 |
|
genetics |
|
GE |
|
Q000254 |
|
growth & development |
|
GD |
|
Q000276 |
|
immunology |
|
IM |
|
Q000302 |
|
isolation & purification |
|
IP |
|
Q000378 |
|
metabolism |
|
ME |
|
Q000472 |
|
pathogenicity |
|
PY |
|
Q000502 |
|
physiology |
|
PH |
|
Q000528 |
|
radiation effects |
|
RE |
|
Q000648 |
|
ultrastructure |
|
UL |
|
Q000737 |
|
chemistry |
|
CH |
|
infection: coord IM with RETROVIRIDAE INFECTIONS (IM) + TUMOR VIRUS INFECTIONS (IM) + LEUKEMIA, EXPERIMENTAL (IM) |
|
2002 (1980) |
|
2002; see ABELSON LEUKEMIA VIRUS 1991-2001, see MOUSE LEUKEMIA VIRUSES 1980-1990 |
|
Mouse Leukemia Viruses (1966-1979) |
|
B04.613.807.375.525.020 |
|
B04.820.650.375.525.020 |
|
M0000011 |
|
Abelson murine leukemia virus |
|
A replication-defective strain of Murine leukemia virus (LEUKEMIA VIRUS, MURINE) capable of transforming lymphoid cells and producing a rapidly progressing lymphoid leukemia after superinfection with FRIEND MURINE LEUKEMIA VIRUS; MOLONEY MURINE LEUKEMIA VIRUS; or RAUSCHER VIRUS. |
|
T445670 |
|
Abelson murine leukemia virus |
|
2001 |
|
05 |
|
04 |
|
NLM (2002) |
|
T000023 |
|
Abelson Leukemia Virus |
|
1999 |
|
01 |
|
01 |
|
NLM (1980) |
|
T000023 |
|
Leukemia Virus, Abelson |
|
T000023 |
|
Virus, Abelson Leukemia |
|
D000012 |
|
Abetalipoproteinemia |
|
1999 |
|
01 |
|
01 |
|
2013 |
|
07 |
|
08 |
|
1966 |
|
01 |
|
01 |
|
Q000469 |
|
parasitology |
|
PS |
|
Q000276 |
|
immunology |
|
IM |
|
Q000382 |
|
microbiology |
|
MI |
|
Q000175 |
|
diagnosis |
|
DI |
|
Q000000981 |
|
diagnostic imaging |
|
DG |
|
Q000503 |
|
physiopathology |
|
PP |
|
Q000534 |
|
rehabilitation |
|
RH |
|
Q000201 |
|
enzymology |
|
EN |
|
Q000209 |
|
etiology |
|
ET |
|
Q000401 |
|
mortality |
|
MO |
|
Q000453 |
|
epidemiology |
|
EP |
|
Q000517 |
|
prevention & control |
|
PC |
|
Q000097 |
|
blood |
|
BL |
|
Q000134 |
|
cerebrospinal fluid |
|
CF |
|
Q000139 |
|
chemically induced |
|
CI |
|
Q000178 |
|
diet therapy |
|
DH |
|
Q000188 |
|
drug therapy |
|
DT |
|
Q000628 |
|
therapy |
|
TH |
|
Q000523 |
|
psychology |
|
PX |
|
Q000652 |
|
urine |
|
UR |
|
Q000821 |
|
virology |
|
VI |
|
Q000662 |
|
veterinary |
|
VE |
|
Q000266 |
|
history |
|
HI |
|
Q000145 |
|
classification |
|
CL |
|
Q000150 |
|
complications |
|
CO |
|
Q000191 |
|
economics |
|
EC |
|
Q000196 |
|
embryology |
|
EM |
|
Q000235 |
|
genetics |
|
GE |
|
Q000378 |
|
metabolism |
|
ME |
|
Q000451 |
|
nursing |
|
NU |
|
Q000532 |
|
radiotherapy |
|
RT |
|
Q000601 |
|
surgery |
|
SU |
|
Q000208 |
|
ethnology |
|
EH |
|
Q000473 |
|
pathology |
|
PA |
|
1966(1964) |
|
1966 |
|
C16.320.565.398.500.440.500 |
|
C18.452.584.500.875.440.500 |
|
C18.452.648.398.500.440.500 |
|
M0000012 |
|
Abetalipoproteinemia |
|
An autosomal recessive disorder of lipid metabolism. It is caused by mutation of the microsomal triglyceride transfer protein that catalyzes the transport of lipids (TRIGLYCERIDES; CHOLESTEROL ESTERS; PHOSPHOLIPIDS) and is required in the secretion of BETA-LIPOPROTEINS (low density lipoproteins or LDL). Features include defective intestinal lipid absorption, very low serum cholesterol level, and near absent LDL. |
|
T000024 |
|
Abetalipoproteinemia |
|
1999 |
|
01 |
|
01 |
|
GHR (2014) |
|
NLM (1964) |
|
OMIM (2013) |
|
ORD (2010) |
|
T365904 |
|
Bassen-Kornzweig Disease |
|
1999 |
|
11 |
|
04 |
|
BASSEN KORNZWEIG DIS |
|
NLM (2000) |
|
T365904 |
|
Bassen Kornzweig Disease |
|
T365903 |
|
Microsomal Triglyceride Transfer Protein Deficiency Disease |
|
1999 |
|
11 |
|
04 |
|
MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN DEFIC DIS |
|
GHR (2014) |
|
NLM (2000) |
|
ORD (2010) |
|
T751239 |
|
Betalipoprotein Deficiency Disease |
|
2009 |
|
05 |
|
14 |
|
GHR (2014) |
|
NLM (2010) |
|
ORD (2010) |
|
T751239 |
|
Betalipoprotein Deficiency Diseases |
|
T751239 |
|
Deficiency Disease, Betalipoprotein |
|
T751239 |
|
Deficiency Diseases, Betalipoprotein |
|
T751239 |
|
Disease, Betalipoprotein Deficiency |
|
T751239 |
|
Diseases, Betalipoprotein Deficiency |
|
T646365 |
|
Microsomal Triglyceride Transfer Protein Deficiency |
|
2005 |
|
07 |
|
20 |
|
MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN DEFIC |
|
NLM (2007) |
|
OMIM (2013) |
|
T811395 |
|
Acanthocytosis |
|
2011 |
|
11 |
|
15 |
|
GHR (2014) |
|
OMIM (2013) |
|
T811395 |
|
Acanthocytoses |
|
T000025 |
|
Bassen-Kornzweig Syndrome |
|
1974 |
|
03 |
|
29 |
|
GHR (2014) |
|
OMIM (2013) |
|
ORD (2010) |
|
UNK (19XX) |
|
T000025 |
|
Bassen Kornzweig Syndrome |
|
D000013 |
|
Congenital Abnormalities |
|
1999 |
|
01 |
|
01 |
|
2007 |
|
07 |
|
09 |
|
2008 |
|
01 |
|
01 |
|
Q000469 |
|
parasitology |
|
PS |
|
Q000276 |
|
immunology |
|
IM |
|
Q000382 |
|
microbiology |
|
MI |
|
Q000175 |
|
diagnosis |
|
DI |
|
Q000000981 |
|
diagnostic imaging |
|
DG |
|
Q000503 |
|
physiopathology |
|
PP |
|
Q000534 |
|
rehabilitation |
|
RH |
|
Q000201 |
|
enzymology |
|
EN |
|
Q000209 |
|
etiology |
|
ET |
|
Q000401 |
|
mortality |
|
MO |
|
Q000453 |
|
epidemiology |
|
EP |
|
Q000517 |
|
prevention & control |
|
PC |
|
Q000097 |
|
blood |
|
BL |
|
Q000134 |
|
cerebrospinal fluid |
|
CF |
|
Q000178 |
|
diet therapy |
|
DH |
|
Q000188 |
|
drug therapy |
|
DT |
|
Q000628 |
|
therapy |
|
TH |
|
Q000523 |
|
psychology |
|
PX |
|
Q000652 |
|
urine |
|
UR |
|
Q000821 |
|
virology |
|
VI |
|
Q000662 |
|
veterinary |
|
VE |
|
Q000266 |
|
history |
|
HI |
|
Q000145 |
|
classification |
|
CL |
|
Q000191 |
|
economics |
|
EC |
|
Q000196 |
|
embryology |
|
EM |
|
Q000235 |
|
genetics |
|
GE |
|
Q000378 |
|
metabolism |
|
ME |
|
Q000451 |
|
nursing |
|
NU |
|
Q000532 |
|
radiotherapy |
|
RT |
|
Q000601 |
|
surgery |
|
SU |
|
Q000208 |
|
ethnology |
|
EH |
|
Q000473 |
|
pathology |
|
PA |
|
general only: prefer /abnorm with specific anatomical term or specific animal: Manual 19.7+, 19.8.1; policy: Manual 23.20+ |
|
2008 (1963) |
|
2008; see ABNORMALITIES 1963-2007 |
|
D000013 |
|
Congenital Abnormalities |
|
Q000139 |
|
chemically induced |
|
D000014 |
|
Abnormalities, Drug-Induced |
|
C16.131 |
|
M0000013 |
|
Congenital Abnormalities |
|
Malformations of organs or body parts during development in utero. |
|
T000029 |
|
Congenital Abnormalities |
|
1978 |
|
12 |
|
18 |
|
CONGEN ABNORM |
|
NLM (1980) |
|
T000029 |
|
Abnormality, Congenital |
|
T000029 |
|
Congenital Abnormality |
|
T000032 |
|
Deformities |
|
1974 |
|
03 |
|
29 |
|
UNK (19XX) |
|
T000032 |
|
Deformity |
|
T000031 |
|
Congenital Defects |
|
1977 |
|
03 |
|
22 |
|
CONGEN DEFECTS |
|
UNK (19XX) |
|
T000031 |
|
Congenital Defect |
|
T000031 |
|
Defect, Congenital |
|
T000030 |
|
Defects, Congenital |
|
1977 |
|
03 |
|
22 |
|
DEFECTS CONGEN |
|
UNK (19XX) |
|
T000028 |
|
Abnormalities, Congenital |
|
1978 |
|
12 |
|
18 |
|
ABNORM CONGEN |
|
UNK (19XX) |
|
T000027 |
|
Birth Defects |
|
1976 |
|
05 |
|
08 |
|
UNK (19XX) |
|
T000027 |
|
Birth Defect |
|
T000027 |
|
Defect, Birth |
|
T000027 |
|
Defects, Birth |
|
D000014 |
|
Abnormalities, Drug-Induced |
|
1999 |
|
01 |
|
01 |
|
2013 |
|
07 |
|
08 |
|
1964 |
|
01 |
|
01 |
|
Q000469 |
|
parasitology |
|
PS |
|
Q000276 |
|
immunology |
|
IM |
|
Q000382 |
|
microbiology |
|
MI |
|
Q000175 |
|
diagnosis |
|
DI |
|
Q000000981 |
|
diagnostic imaging |
|
DG |
|
Q000503 |
|
physiopathology |
|
PP |
|
Q000534 |
|
rehabilitation |
|
RH |
|
Q000201 |
|
enzymology |
|
EN |
|
Q000209 |
|
etiology |
|
ET |
|
Q000401 |
|
mortality |
|
MO |
|
Q000453 |
|
epidemiology |
|
EP |
|
Q000517 |
|
prevention & control |
|
PC |
|
Q000097 |
|
blood |
|
BL |
|
Q000134 |
|
cerebrospinal fluid |
|
CF |
|
Q000178 |
|
diet therapy |
|
DH |
|
Q000188 |
|
drug therapy |
|
DT |
|
Q000628 |
|
therapy |
|
TH |
|
Q000523 |
|
psychology |
|
PX |
|
Q000652 |
|
urine |
|
UR |
|
Q000821 |
|
virology |
|
VI |
|
Q000662 |
|
veterinary |
|
VE |
|
Q000266 |
|
history |
|
HI |
|
Q000145 |
|
classification |
|
CL |
|
Q000191 |
|
economics |
|
EC |
|
Q000196 |
|
embryology |
|
EM |
|
Q000235 |
|
genetics |
|
GE |
|
Q000378 |
|
metabolism |
|
ME |
|
Q000451 |
|
nursing |
|
NU |
|
Q000532 |
|
radiotherapy |
|
RT |
|
Q000601 |
|
surgery |
|
SU |
|
Q000208 |
|
ethnology |
|
EH |
|
Q000473 |
|
pathology |
|
PA |
|
IM; do not use /chem ind /compl /congen & do not coord with INFANT, NEWBORN, DISEASES; coord IM with specific chem /adv eff-pois-tox (IM) + specific organ /abnorm or specific abnorm /chem ind (IM); Manual 23.20.3 |
|
64 |
|
QS 679 |
|
64 |
|
D013723 |
|
Teratogens |
|
D064793 |
|
Teratogenesis |
|
C16.131.042 |
|
M0000014 |
|
Abnormalities, Drug-Induced |
|
Congenital abnormalities caused by medicinal substances or drugs of abuse given to or taken by the mother, or to which she is inadvertently exposed during the manufacture of such substances. The concept excludes abnormalities resulting from exposure to non-medicinal chemicals in the environment. |
|
T000034 |
|
Abnormalities, Drug-Induced |
|
1999 |
|
01 |
|
01 |
|
ABNORM DRUG IND |
|
NLM (1964) |
|
T000034 |
|
Abnormalities, Drug Induced |
|
T000033 |
|
Drug-Induced Abnormalities |
|
1977 |
|
12 |
|
07 |
|
DRUG IND ABNORM |
|
UNK (19XX) |
|
T000033 |
|
Abnormality, Drug-Induced |
|
T000033 |
|
Drug Induced Abnormalities |
|
T000033 |
|
Drug-Induced Abnormality |
|
D000015 |
|
Abnormalities, Multiple |
|
1999 |
|
01 |
|
01 |
|
2015 |
|
12 |
|
01 |
|
1968 |
|
01 |
|
01 |
|
Q000469 |
|
parasitology |
|
PS |
|
Q000276 |
|
immunology |
|
IM |
|
Q000382 |
|
microbiology |
|
MI |
|
Q000175 |
|
diagnosis |
|
DI |
|
Q000000981 |
|
diagnostic imaging |
|
DG |
|
Q000503 |
|
physiopathology |
|
PP |
|
Q000534 |
|
rehabilitation |
|
RH |
|
Q000201 |
|
enzymology |
|
EN |
|
Q000209 |
|
etiology |
|
ET |
|
Q000401 |
|
mortality |
|
MO |
|
Q000453 |
|
epidemiology |
|
EP |
|
Q000517 |
|
prevention & control |
|
PC |
|
Q000097 |
|
blood |
|
BL |
|
Q000134 |
|
cerebrospinal fluid |
|
CF |
|
Q000139 |
|
chemically induced |
|
CI |
|
Q000178 |
|
diet therapy |
|
DH |
|
Q000188 |
|
drug therapy |
|
DT |
|
Q000628 |
|
therapy |
|
TH |
|
Q000523 |
|
psychology |
|
PX |
|
Q000652 |
|
urine |
|
UR |
|
Q000821 |
|
virology |
|
VI |
|
Q000662 |
|
veterinary |
|
VE |
|
Q000266 |
|
history |
|
HI |
|
Q000145 |
|
classification |
|
CL |
|
Q000191 |
|
economics |
|
EC |
|
Q000196 |
|
embryology |
|
EM |
|
Q000235 |
|
genetics |
|
GE |
|
Q000378 |
|
metabolism |
|
ME |
|
Q000451 |
|
nursing |
|
NU |
|
Q000532 |
|
radiotherapy |
|
RT |
|
Q000601 |
|
surgery |
|
SU |
|
Q000208 |
|
ethnology |
|
EH |
|
Q000473 |
|
pathology |
|
PA |
|
coordinate with specific abnormalities |
|
68 |
|
QS 675 |
|
68 |
|
Abnormalities (1966-1967) |
|
D008607 |
|
Intellectual Disability |
|
C16.131.077 |
|
M0000015 |
|
Abnormalities, Multiple |
|
Congenital abnormalities that affect more than one organ or body structure. |
|
T000036 |
|
Abnormalities, Multiple |
|
1999 |
|
01 |
|
01 |
|
ABNORM MULTIPLE |
|
NLM (1968) |
|
T000035 |
|
Multiple Abnormalities |
|
1986 |
|
01 |
|
01 |
|
MULTIPLE ABNORM |
|
UNK (19XX) |
|
D000016 |
|
Abnormalities, Radiation-Induced |
|
1978 |
|
03 |
|
20 |
|
2015 |
|
06 |
|
22 |
|
1979 |
|
01 |
|
01 |
|
Q000469 |
|
parasitology |
|
PS |
|
Q000276 |
|
immunology |
|
IM |
|
Q000382 |
|
microbiology |
|
MI |
|
Q000175 |
|
diagnosis |
|
DI |
|
Q000000981 |
|
diagnostic imaging |
|
DG |
|
Q000503 |
|
physiopathology |
|
PP |
|
Q000534 |
|
rehabilitation |
|
RH |
|
Q000201 |
|
enzymology |
|
EN |
|
Q000209 |
|
etiology |
|
ET |
|
Q000401 |
|
mortality |
|
MO |
|
Q000453 |
|
epidemiology |
|
EP |
|
Q000517 |
|
prevention & control |
|
PC |
|
Q000097 |
|
blood |
|
BL |
|
Q000134 |
|
cerebrospinal fluid |
|
CF |
|
Q000178 |
|
diet therapy |
|
DH |
|
Q000188 |
|
drug therapy |
|
DT |
|
Q000628 |
|
therapy |
|
TH |
|
Q000523 |
|
psychology |
|
PX |
|
Q000652 |
|
urine |
|
UR |
|
Q000821 |
|
virology |
|
VI |
|
Q000662 |
|
veterinary |
|
VE |
|
Q000266 |
|
history |
|
HI |
|
Q000145 |
|
classification |
|
CL |
|
Q000191 |
|
economics |
|
EC |
|
Q000196 |
|
embryology |
|
EM |
|
Q000235 |
|
genetics |
|
GE |
|
Q000378 |
|
metabolism |
|
ME |
|
Q000451 |
|
nursing |
|
NU |
|
Q000532 |
|
radiotherapy |
|
RT |
|
Q000601 |
|
surgery |
|
SU |
|
Q000208 |
|
ethnology |
|
EH |
|
Q000473 |
|
pathology |
|
PA |
|
IM; do not use /compl /congen & do not coord with INFANT, NEWBORN, DISEASES; coord IM with specific abnorm (IM) |
|
79 |
|
QS 681 |
|
79 |
|
Abnormalities (1966-1978) |
|
Radiation Injuries (1966-1978) |
|
D064793 |
|
Teratogenesis |
|
C16.131.080 |
|
C26.733.031 |
|
G01.750.748.500.031 |
|
N06.850.460.350.850.500.031 |
|
N06.850.810.300.360.031 |
|
M0000016 |
|
Abnormalities, Radiation-Induced |
|
Congenital changes in the morphology of organs produced by exposure to ionizing or non-ionizing radiation. |
|
T000038 |
|
Abnormalities, Radiation-Induced |
|
1999 |
|
01 |
|
01 |
|
ABNORM RAD IND |
|
NLM (1979) |
|
T000038 |
|
Abnormalities, Radiation Induced |
|
T000037 |
|
Radiation-Induced Abnormalities |
|
1978 |
|
03 |
|
20 |
|
RAD IND ABNORM |
|
UNK (19XX) |
|
T000037 |
|
Abnormality, Radiation-Induced |
|
T000037 |
|
Radiation Induced Abnormalities |
|
T000037 |
|
Radiation-Induced Abnormality |
|
D000017 |
|
ABO Blood-Group System |
|
1975 |
|
07 |
|
25 |
|
2005 |
|
06 |
|
30 |
|
1976 |
|
01 |
|
01 |
|
Q000276 |
|
immunology |
|
IM |
|
Q000096 |
|
biosynthesis |
|
BI |
|
Q000502 |
|
physiology |
|
PH |
|
Q000627 |
|
therapeutic use |
|
TU |
|
Q000633 |
|
toxicity |
|
TO |
|
Q000506 |
|
poisoning |
|
PO |
|
Q000008 |
|
administration & dosage |
|
AD |
|
Q000009 |
|
adverse effects |
|
AE |
|
Q000097 |
|
blood |
|
BL |
|
Q000134 |
|
cerebrospinal fluid |
|
CF |
|
Q000744 |
|
contraindications |
|
CT |
|
Q000737 |
|
chemistry |
|
CH |
|
Q000652 |
|
urine |
|
UR |
|
Q000266 |
|
history |
|
HI |
|
Q000032 |
|
analysis |
|
AN |
|
Q000145 |
|
classification |
|
CL |
|
Q000191 |
|
economics |
|
EC |
|
Q000235 |
|
genetics |
|
GE |
|
Q000302 |
|
isolation & purification |
|
IP |
|
Q000378 |
|
metabolism |
|
ME |
|
Q000494 |
|
pharmacology |
|
PD |
|
Q000648 |
|
ultrastructure |
|
UL |
|
IM; coord with disease /blood (IM), not /immunol nor /genet; TN 230 |
|
76; was ABO FACTORS 1963-75 |
|
WH 420 |
|
use ABO BLOOD-GROUP SYSTEM to search ABO FACTORS 1966-75 |
|
76; was ABO FACTORS 1963-75 |
|
D23.050.301.290.031 |
|
D23.050.705.230.031 |
|
M0000017 |
|
ABO Blood-Group System |
|
0 |
|
The major human blood type system which depends on the presence or absence of two antigens A and B. Type O occurs when neither A nor B is present and AB when both are present. A and B are genetic factors that determine the presence of enzymes for the synthesis of certain glycoproteins mainly in the red cell membrane. |
|
M0000017 |
|
M0000019 |
|
M0000017 |
|
M0000018 |
|
T000040 |
|
ABO Blood-Group System |
|
1999 |
|
01 |
|
01 |
|
NLM (1976) |
|
T000040 |
|
ABO Blood Group System |
|
T000040 |
|
ABO Blood-Group Systems |
|
T000040 |
|
Blood-Group System, ABO |
|
T000040 |
|
Blood-Group Systems, ABO |
|
T000040 |
|
System, ABO Blood-Group |
|
T000040 |
|
Systems, ABO Blood-Group |
|
T000042 |
|
H Blood Group System |
|
1984 |
|
09 |
|
20 |
|
UNK (19XX) |
|
T000041 |
|
H Blood Group |
|
1980 |
|
08 |
|
04 |
|
UNK (19XX) |
|
T000041 |
|
Blood Group, H |
|
T000041 |
|
Blood Groups, H |
|
T000041 |
|
H Blood Groups |
|
T000039 |
|
ABH Blood Group |
|
1988 |
|
06 |
|
07 |
|
UNK (19XX) |
|
T000039 |
|
ABH Blood Groups |
|
T000039 |
|
Blood Group, ABH |
|
T000039 |
|
Blood Groups, ABH |
|
M0000019 |
|
Blood Group H Type 1 Antigen |
|
0 |
|
M0000017 |
|
M0000019 |
|
T000044 |
|
Blood Group H Type 1 Antigen |
|
1984 |
|
03 |
|
05 |
|
UNK (19XX) |
|
M0000018 |
|
ABO Factors |
|
0 |
|
M0000017 |
|
M0000018 |
|
T000043 |
|
ABO Factors |
|
1975 |
|
07 |
|
22 |
|
UNK (19XX) |
|
T000043 |
|
ABO Factor |
|
T000043 |
|
Factor, ABO |
|
T000043 |
|
Factors, ABO |
|
D000018 |
|
Abomasum |
|
1999 |
|
01 |
|
01 |
|
1995 |
|
05 |
|
18 |
|
1968 |
|
01 |
|
01 |
|
Q000469 |
|
parasitology |
|
PS |
|
Q000002 |
|
abnormalities |
|
AB |
|
Q000276 |
|
immunology |
|
IM |
|
Q000382 |
|
microbiology |
|
MI |
|
Q000000981 |
|
diagnostic imaging |
|
DG |
|
Q000502 |
|
physiology |
|
PH |
|
Q000503 |
|
physiopathology |
|
PP |
|
Q000557 |
|
secretion |
|
SE |
|
Q000201 |
|
enzymology |
|
EN |
|
Q000294 |
|
innervation |
|
IR |
|
Q000166 |
|
cytology |
|
CY |
|
Q000737 |
|
chemistry |
|
CH |
|
Q000187 |
|
drug effects |
|
DE |
|
Q000637 |
|
transplantation |
|
TR |
|
Q000821 |
|
virology |
|
VI |
|
Q000528 |
|
radiation effects |
|
RE |
|
Q000033 |
|
anatomy & histology |
|
AH |
|
Q000098 |
|
blood supply |
|
BS |
|
Q000196 |
|
embryology |
|
EM |
|
Q000254 |
|
growth & development |
|
GD |
|
Q000293 |
|
injuries |
|
IN |
|
Q000378 |
|
metabolism |
|
ME |
|
Q000601 |
|
surgery |
|
SU |
|
Q000473 |
|
pathology |
|
PA |
|
Q000648 |
|
ultrastructure |
|
UL |
|
a ruminant's 4th stomach; dis: coord IM with STOMACH DISEASES /vet (IM); neopl: coord IM with STOMACH NEOPLASMS /vet (IM) + histol type /vet (IM); ulcer: coord IM with STOMACH ULCER /vet (IM) |
|
68 |
|
QL 862 |
|
68 |
|
Stomach (1966-1967) |
|
A13.869.106 |
|
M0000020 |
|
Abomasum |
|
The fourth stomach of ruminating animals. It is also called the "true" stomach. It is an elongated pear-shaped sac lying on the floor of the abdomen, on the right-hand side, and roughly between the seventh and twelfth ribs. It leads to the beginning of the small intestine. (From Black's Veterinary Dictionary, 17th ed) |
|
T000045 |
|
Abomasum |
|
1999 |
|
01 |
|
01 |
|
NLM (1968) |
|
T000045 |
|
Abomasums |
|
D000019 |
|
Abortifacient Agents |
|
1999 |
|
01 |
|
01 |
|
2014 |
|
06 |
|
25 |
|
1975 |
|
01 |
|
01 |
|
Q000276 |
|
immunology |
|
IM |
|
Q000493 |
|
pharmacokinetics |
|
PK |
|
Q000627 |
|
therapeutic use |
|
TU |
|
Q000633 |
|
toxicity |
|
TO |
|
Q000506 |
|
poisoning |
|
PO |
|
Q000008 |
|
administration & dosage |
|
AD |
|
Q000009 |
|
adverse effects |
|
AE |
|
Q000097 |
|
blood |
|
BL |
|
Q000134 |
|
cerebrospinal fluid |
|
CF |
|
Q000138 |
|
chemical synthesis |
|
CS |
|
Q000744 |
|
contraindications |
|
CT |
|
Q000737 |
|
chemistry |
|
CH |
|
Q000652 |
|
urine |
|
UR |
|
Q000528 |
|
radiation effects |
|
RE |
|
Q000266 |
|
history |
|
HI |
|
Q000032 |
|
analysis |
|
AN |
|
Q000145 |
|
classification |
|
CL |
|
Q000191 |
|
economics |
|
EC |
|
Q000302 |
|
isolation & purification |
|
IP |
|
Q000378 |
|
metabolism |
|
ME |
|
Q000494 |
|
pharmacology |
|
PD |
|
Q000592 |
|
standards |
|
ST |
|
Q000600 |
|
supply & distribution |
|
SD |
|
use no qualifiers for abortifacients when used to interrupt pregnancy; note entry term ABORTIFACIENT EFFECT: use only for the abortifacient effect of a chemical substance |
|
75 |
|
QV 175 |
|
75 |
|
Abortion, Induced (1970-1974) |
|
D010120 |
|
Oxytocics |
|
D27.505.696.875.131 |
|
D27.505.954.705.131 |
|
M0000021 |
|
Abortifacient Agents |
|
0 |
|
Chemical substances that interrupt pregnancy after implantation. |
|
M0000021 |
|
M0556260 |
|
T000046 |
|
Abortifacient Agents |
|
1999 |
|
01 |
|
01 |
|
POPLINE (1978) |
|
T000046 |
|
Agents, Abortifacient |
|
T000047 |
|
Contraceptive Agents, Postconception |
|
1978 |
|
12 |
|
18 |
|
POPLINE (1978) |
|
T000047 |
|
Agents, Postconception Contraceptive |
|
T000047 |
|
Postconception Contraceptive Agents |
|
T000048 |
|
Abortifacients |
|
1991 |
|
10 |
|
09 |
|
NLM (1993) |
|
M0556260 |
|
Abortifacient Effect |
|
0 |
|
M0000021 |
|
M0556260 |
|
T788179 |
|
Abortifacient Effect |
|
2011 |
|
03 |
|
31 |
|
NLM (2012) |
|
T788179 |
|
Effect, Abortifacient |
|
T788180 |
|
Abortifacient Effects |
|
2011 |
|
03 |
|
31 |
|
NLM (2012) |
|
T788180 |
|
Effects, Abortifacient |
|
D000020 |
|
Abortifacient Agents, Nonsteroidal |
|
1974 |
|
11 |
|
11 |
|
2014 |
|
06 |
|
25 |
|
1991 |
|
01 |
|
01 |
|
Q000276 |
|
immunology |
|
IM |
|
Q000493 |
|
pharmacokinetics |
|
PK |
|
Q000627 |
|
therapeutic use |
|
TU |
|
Q000633 |
|
toxicity |
|
TO |
|
Q000506 |
|
poisoning |
|
PO |
|
Q000008 |
|
administration & dosage |
|
AD |
|
Q000009 |
|
adverse effects |
|
AE |
|
Q000097 |
|
blood |
|
BL |
|
Q000134 |
|
cerebrospinal fluid |
|
CF |
|
Q000138 |
|
chemical synthesis |
|
CS |
|
Q000744 |
|
contraindications |
|
CT |
|
Q000737 |
|
chemistry |
|
CH |
|
Q000652 |
|
urine |
|
UR |
|
Q000528 |
|
radiation effects |
|
RE |
|
Q000266 |
|
history |
|
HI |
|
Q000032 |
|
analysis |
|
AN |
|
Q000145 |
|
classification |
|
CL |
|
Q000191 |
|
economics |
|
EC |
|
Q000302 |
|
isolation & purification |
|
IP |
|
Q000378 |
|
metabolism |
|
ME |
|
Q000494 |
|
pharmacology |
|
PD |
|
Q000592 |
|
standards |
|
ST |
|
Q000600 |
|
supply & distribution |
|
SD |
|
do not use /ther use for use of the abortifacients as abortifacients |
|
91(75); was see under ABORTIFACIENT AGENTS 1975-90 |
|
QV 175 |
|
91; was see under ABORTIFACIENT AGENTS 1975-90 |
|
Abortion, Induced (1970-1974) |
|
specific chemical (1971-1974) |
|
D27.505.696.875.131.100 |
|
D27.505.954.705.131.100 |
|
M0000022 |
|
Abortifacient Agents, Nonsteroidal |
|
0 |
|
Non-steroidal chemical compounds with abortifacient activity. |
|
T000050 |
|
Abortifacient Agents, Nonsteroidal |
|
1999 |
|
01 |
|
01 |
|
NLM (1975) |
|
T000050 |
|
Agents, Nonsteroidal Abortifacient |
|
T000050 |
|
Nonsteroidal Abortifacient Agents |
|
T000049 |
|
Abortifacient Agents, Non-Steroidal |
|
1977 |
|
12 |
|
07 |
|
UNK (19XX) |
|
T000049 |
|
Abortifacient Agents, Non Steroidal |
|
T000049 |
|
Agents, Non-Steroidal Abortifacient |
|
T000049 |
|
Non-Steroidal Abortifacient Agents |
|
D000021 |
|
Abortifacient Agents, Steroidal |
|
1974 |
|
11 |
|
11 |
|
2005 |
|
06 |
|
30 |
|
1991 |
|
01 |
|
01 |
|
Q000276 |
|
immunology |
|
IM |
|
Q000493 |
|
pharmacokinetics |
|
PK |
|
Q000627 |
|
therapeutic use |
|
TU |
|
Q000633 |
|
toxicity |
|
TO |
|
Q000506 |
|
poisoning |
|
PO |
|
Q000008 |
|
administration & dosage |
|
AD |
|
Q000009 |
|
adverse effects |
|
AE |
|
Q000819 |
|
agonists |
|
AG |
|
Q000097 |
|
blood |
|
BL |
|
Q000134 |
|
cerebrospinal fluid |
|
CF |
|
Q000138 |
|
chemical synthesis |
|
CS |
|
Q000744 |
|
contraindications |
|
CT |
|
Q000737 |
|
chemistry |
|
CH |
|
Q000652 |
|
urine |
|
UR |
|
Q000528 |
|
radiation effects |
|
RE |
|
Q000266 |
|
history |
|
HI |
|
Q000032 |
|
analysis |
|
AN |
|
Q000037 |
|
antagonists & inhibitors |
|
AI |
|
Q000145 |
|
classification |
|
CL |
|
Q000191 |
|
economics |
|
EC |
|
Q000302 |
|
isolation & purification |
|
IP |
|
Q000378 |
|
metabolism |
|
ME |
|
Q000494 |
|
pharmacology |
|
PD |
|
Q000592 |
|
standards |
|
ST |
|
Q000600 |
|
supply & distribution |
|
SD |
|
do not use /ther use for use of the abortifacients as abortifacients |
|
91(75); was see under ABORTIFACIENT AGENTS 1975-90 |
|
QV 175 |
|
91; was see under ABORTIFACIENT AGENTS 1975-90 |
|
Abortion, Induced (1970-1974) |
|
specific chemical (1970-1974) |
|
D27.505.696.875.131.200 |
|
D27.505.954.705.131.200 |
|
M0000023 |
|
Abortifacient Agents, Steroidal |
|
0 |
|
Steroidal compounds with abortifacient activity. |
|
T000051 |
|
Abortifacient Agents, Steroidal |
|
1999 |
|
01 |
|
01 |
|
NLM (1975) |
|
T000051 |
|
Agents, Steroidal Abortifacient |
|
T000051 |
|
Steroidal Abortifacient Agents |
|
T000052 |
|
Steroid Abortifacients |
|
1978 |
|
12 |
|
18 |
|
POPLINE (1978) |
|
T000052 |
|
Abortifacients, Steroid |